MBX Biosciences, Inc. MBX
Set alert
55.30 USD +0.90 +1.65%
As of Nov 3, 3:15 PM ET
55.11 Day range 57.10
20.27 52-week range 72.64
- YTD
- +75.32%
- 1 year
- +168.30%
- Open
- 55.11
- Prev close
- 54.40
- Mkt cap
- 2.66B
- Vol
- 120.65K
- Avg vol
- 511.38K
- EPS
- -2.37
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 55.11
- High
- 57.10
- Forward P/E
- -13.68
- Beta
- 0.18
- Short ratio
- 6.96
- Inst. own
- 116.04%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 57.82
- 200-d avg
- 45.58
- 1y target
- 95.70
5D chart
Signals (99)
| Name | Time | Ago |
|---|---|---|
| SMA: Bullish | Nov 3, 9:30 AM | 5 hours ago |
| SMA: Bullish | Nov 3, 9:30 AM | 5 hours ago |
| MACD: Buy Signal | Nov 3, 9:30 AM | 5 hours ago |
| SMA: Bearish | Nov 2, 3:55 PM | 23 hours ago |
| SMA: Bearish | Nov 2, 3:55 PM | 23 hours ago |
| MACD: Sell Signal | Nov 2, 3:55 PM | 23 hours ago |
| SMA: Bullish | Nov 2, 3:45 PM | 23 hours ago |
| SMA: Bullish | Nov 2, 3:40 PM | 23 hours ago |
| MACD: Buy Signal | Nov 2, 3:40 PM | 23 hours ago |
| MACD: Sell Signal | Nov 2, 3:35 PM | 23 hours ago |
| SMA: Bearish | Nov 2, 3:20 PM | 23 hours ago |
| SMA: Bullish | Nov 2, 2:55 PM | 1 day ago |
| SMA: Bullish | Nov 2, 2:40 PM | 1 day ago |
| SMA: Bearish | Nov 2, 2:35 PM | 1 day ago |
| SMA: Bullish | Nov 2, 2:25 PM | 1 day ago |
| MACD: Buy Signal | Nov 2, 2:25 PM | 1 day ago |
| SMA: Bearish | Nov 2, 2:15 PM | 1 day ago |
| SMA: Bullish | Nov 2, 2:10 PM | 1 day ago |
| MACD: Sell Signal | Nov 2, 1:35 PM | 1 day ago |
| SMA: Bearish | Nov 2, 1:25 PM | 1 day ago |
Newest 20 of 99.
Financial health
Altman Z-Score
58.99 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 1
Valuation
P/E -13.3×
FY 2022 5y median -18.2× FY 2025
P/S 0.0×
FY 2022 5y median 0.0× FY 2025
P/B 3.1×
FY 2022 5y median -4.0× FY 2025
P/FCF -14.1×
FY 2022 5y median -18.8× FY 2025
EV/EBITDA -12.4×
FY 2022 5y median -17.4× FY 2025
EV/Sales 0.0×
FY 2022 5y median 0.0× FY 2025
FCF Yield -7.1%
FY 2022 5y median -5.7% FY 2025
Profitability
Gross Margin 0.0%
FY 2022 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2022 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2022 5y median 0.0% FY 2025
ROE -23.6%
FY 2022 5y median 10.7% FY 2025
ROIC -26.5%
FY 2022 5y median -35.2% FY 2025
ROA -22.6%
FY 2022 5y median -30.9% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2022 FY 2025
Operating Income -43.8%
FY 2022 FY 2025
EPS (diluted) -28.6%
FY 2022 FY 2025
Free Cash Flow -47.4%
FY 2022 FY 2025
Financial Health
Current Ratio 24.6×
FY 2022 5y median 22.7× FY 2025
Quick Ratio 24.6×
FY 2022 5y median 22.7× FY 2025
Debt / Equity 0.0×
FY 2022 5y median -0.0× FY 2025
Net Debt / EBITDA 0.9×
FY 2022 5y median 0.9× FY 2025
Interest Coverage 0.0×
FY 2022 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2022 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2022 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31